Ricarda Melina Hoffmann

Ricarda Melina Hoffmann is currently serving as an Investment Fellow at BGV (BioGeneration Ventures) since February 2024. Prior to this role, Hoffmann was the Head of Discovery at Valink Therapeutics from January 2022 to December 2023 and held various positions at King's College London between September 2015 and January 2022, including Researcher PhD Student, Laboratory Demonstrator, and Student Representative. Additional experience includes a Postdoctoral Researcher position at The Institute of Cancer Research from October 2020 to December 2021, and multiple research assistant roles at Femtogenix, An Najah National University, University of Costa Rica, and McGill University. Hoffmann obtained a Master of Science in biomedical and translational science research from King's College London in 2015 and a Bachelor of Science in Life Science from the University of Konstanz in 2013.